PHARMACEUTICAL COMPOSITION WITH BASE OF RHEIN OR DIACERHEIN WITH IMPROVED BIOLOGICAL AVAILABILITY

摘要

The invention relates to a pharmaceutical composition based on rhein or diacerhein. The composition is intended for oral, rectal or cutaneous (percutaneous or transdermal) administration, and comprises rhein or diacerhein, or one of their pharmaceutically acceptable salts or esters, and sodium laurysulfate, comicronized, in a weight ratio between 3: 1 and 30: 1. The composition has improved bioavailability.